By Marie Rosenthal, MS
The FDA recently cleared for marketing several tests for infectious diseases.
The FDA cleared two tests that can detect the presence of the bacteria Chlamydia trachomatis and Neisseria gonorrhoeae through diagnostic testing of extragenital specimens. The Aptima Combo 2 Assay (Hologic) and the Xpert CT/NG (Cepheid) are the first devices cleared for extragenital diagnostic testing of these infections via the throat and rectum. These tests were previously only cleared for